Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopa

Clinical trial NCT00381472 · COMPLETED

Trial details

NCT number: NCT00381472
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Parkinson Disease

Start date: 2003-06-01
Enrollment: 393

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.